(Q37998372)

26 August 2017

Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives (English)

1 reference

26 August 2017

Bingxue Shang

1

1 reference

26 August 2017

Zhifei Cao

series ordinal

2

1 reference

26 August 2017

Quansheng Zhou

series ordinal

3

1 reference

26 August 2017

language of work or name

1 reference

31 March 2012

1 reference

26 August 2017

Frontiers of medicine

1 reference

26 August 2017

6

1 reference

26 August 2017

1

1 reference

26 August 2017

67-78

1 reference

https://scigraph.springernature.com/pub.10.1007/s11684-012-0176-8

26 August 2017

0 references

cites work

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Anticancer strategies involving the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Endogenous inhibitors of angiogenesis: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

The discovery of antiangiogenic molecules: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Normalization of the vasculature for treatment of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Persistent vascular normalization as an alternative goal of anti-angiogenic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Ancestral vascular tube formation and its adoption by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Basic and therapeutic aspects of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Precancerous stem cells can serve as tumor vasculogenic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Angiogenesis in pre-malignant conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Cancer stem cells, hypoxia and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Transdifferentiation of glioblastoma cells into vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Consice review: Contribution of cancer stem cells to neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Bone marrow angiogenesis in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Role of macrophages in tumour progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vasculogenic mimicry and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vasculogenic mimicry: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Strategies to improve radiotherapy with targeted drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Cancer stem cells: the lessons from pre-cancerous stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Structure of artificial and natural VE-cadherin-based adherens junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Expression and function of angiopoietin-1 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Biomarkers of response and resistance to antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

PHD2 mutation and congenital erythrocytosis with paraganglioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Breaking the VE-cadherin bonds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

The role of adherens junctions and VE-cadherin in the control of vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

The role of VE-cadherin in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Endothelial cadherins and tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

A fragment of human TrpRS as a potent antagonist of ocular angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Cudratricusxanthone G inhibits human colorectal carcinoma cell invasion by MMP-2 down-regulation through suppressing activator protein-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Down-regulation of telomerase activity and activation of caspase-3 are responsible for Tanshinone I-induced apoptosis in monocyte leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Tumor-associated endothelial cells with cytogenetic abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

The enigmatic role of angiopoietin-1 in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Time-course imaging of therapeutic functional tumor vascular normalization by antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11684-012-0176-8

Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma

21 January 2018

1 reference

12 December 2020

Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma

1 reference

12 December 2020

Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

1 reference

12 December 2020

Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells.

1 reference

12 December 2020

Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis

1 reference

12 December 2020

[Study on the tumor microenvironment and tumor vascular normalization in integrative treatment of tumor by Chinese medicine and western medicine]

1 reference

12 December 2020

Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells.

1 reference

12 December 2020

Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation

1 reference

12 December 2020

You don't need a PHD to grow a tumor

1 reference

12 December 2020

[A concept of regulating tumor microenvironment immune and normalizing angiogenesis by Chinese medicine drug therapy for supporting zheng-qi to prop up root]

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Breviscapine-induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity

1 reference

12 December 2020

Tumor-associated macrophages: effectors of angiogenesis and tumor progression.

1 reference

12 December 2020

Increased vascularization in mice overexpressing angiopoietin-1

1 reference

12 December 2020

Tumor hypoxia and malignant progression.

1 reference

12 December 2020

Polymorphisms of matrix metalloproteinases 1, 2, 3 and 9 and susceptibility to lung, breast and colorectal cancer in over 30,000 subjects

1 reference

12 December 2020

Oncogenes, p53, and tumor angiogenesis

1 reference

12 December 2020

Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells

1 reference

12 December 2020

Lessons From the Adjuvant Bevacizumab Trial on Colon Cancer: What Next?

1 reference

12 December 2020

10.1007/S11684-012-0176-8

Identifiers

DOI

1 reference

26 August 2017

1 reference